BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Cresset Group to Exhibit and Present at American Chemical Society National Meeting and Exposition


8/6/2012 10:18:05 AM

Welwyn Garden City, UK (28th May 2012) Cresset, innovative provider of software and services for molecule designers, will be exhibiting on booth 409 at the American Chemical Society (ACS) National Meeting and Exposition which takes place in Philadelphia, PA, USA on August 19th – 23rd 2012.

Cresset will also be presenting as follows:

Computation Tools for Medicinal Chemists: Increasing the Dimensions of Drug Discovery

by Dr Robert Scoffin, Chief Executive Officer

Session: When Chemists and Computers Collide: Putting Cheminformatics in the Hands of Medicinal Chemists

August 19, 2012 from 10:15 am to 10:45 am; Philadelphia Marriott Downtown, Room 302/303

Identifying Novel Bioisosteres

by Dr Tim Cheeseright, Director of Products

Session: Bioisosteres Redux: Strategic Deployment in the Design and Development of Drug Candidates

August 22, 2012 from 9:10 am to 9:50 am; Pennsylvania Convention Center, Room Ballroom IV

Optimising your leads for potency AND drug-likeness – how to have it all

by Dr Robert Scoffin, Chief Executive Officer

Session: Optibrium StarDrop User Group and Workshop

August 22, 2012 from 12:00 pm to 14:30 pm; Pennsylvania Convention Center, Room 202A

Disruptive Technology for Chemical Patent Fortification

by Dr Rae Lawrence, Technical Sales Manager

Session: The Many Faces of CHAL: Where Chemistry Meets the Law

August 23, 2012 from 4:25 pm to 4:50 pm; Pennsylvania Convention Center, Room 113 C

Cresset CEO, Dr Robert Scoffin, said, “We are delighted to be participating in this event again. The ACS national meeting attracts chemists from around the world and enables them to learn about cutting edge technologies, such as our range of next generation chemistry software and services. Each of our presentations will present thought-provoking and enlightening methods for research. We hope to see you there to demonstrate how Cresset’s tools can set your company on the fast track to novel chemistry.”

Meeting the needs of computational and medicinal chemists, Cresset’s suite of next generation chemistry software comprises: forgeV10 a powerful computational suite to understand SAR and design; torchV10 an intuitive design and 3D SAR tool for medicinal chemists; torchV10lite a free 3D molecule viewing, editing and drawing tool; blazeV10 an amazing ligand based virtual screening tool; sparkV10 an exciting and powerful way of generating novel and diverse structures.

Scientists interested in Cresset’s next generation software can download free demos from the company’s website.

For further information on the complete range of software and services available from Cresset, please visit us on booth 409 at the ACS National Meeting and Exposition, visit www.cresset-group.com, follow Cresset on Twitter (@cressetgroup) or join the LinkedIn group.

About Cresset Group Ltd

Cresset develops software for calculating and comparing the molecular field characteristics of chemical compounds. Field technology uses the surface properties of molecules to evaluate their activities and properties, rather than relying on 2D structure similarity, which enables Cresset’s customers to find more interesting, novel and relevant results than other methods. Cresset’s fields provide a smarter, structure independent way of hit-finding, lead switching and lead optimization in drug discovery and other chemistry-based research projects. Cresset’s field technologies have been successfully applied to a very wide range of target classes, with and without structural information, on over 100 projects for major pharmaceutical and biotechnology companies. www.cresset-group.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->